TP53 and prostate carcinoma: In more advanced prostate cancers, clonal point mutations of tumor suppressor genes such as PTEN [4] and p53 [3] are more common, in contrast to the low frequency of mutation of these genes in localized cancer [5], [6], but are still not common compared to most malignancies.